Search research articles
Contact Us
Filters
Showing results (101-110 of 141) with videos related to
Page
of 15
Sort By:
Cancer Medicine
|
August 10, 2013
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
Timothy J Price, Jennifer E Hardingham, Chee K Lee, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 1, 1993
Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial
P A Gatenby, K Cameron, R J Simes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group
M J Byrne, V Gebski, J Forbes, et al.
The British Journal of Surgery
|
September 10, 2015
Meta-analysis of radical resection rates and margin assessment in pancreatic cancer
M D Chandrasegaram, D Goldstein, J Simes, et al.
Journal of the American College of Cardiology
|
June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators
B K Metz, H D White, C B Granger, et al.
Lancet (London, England)
|
December 29, 2000
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study
A M Tonkin, D Colquhoun, J Emberson, et al.
JAMA
|
December 24, 1997
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review
W D Weaver, R J Simes, A Betriu, et al.
Circulation
|
September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators
R M Califf, H D White, F Van de Werf, et al.
Breast Cancer Research and Treatment
|
April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C
T J Price, D Zannino, K Wilson, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 141) with videos related to
Sort By:
Page
of 15
Cancer Medicine
|
August 10, 2013
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
Timothy J Price, Jennifer E Hardingham, Chee K Lee, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 1, 1993
Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial
P A Gatenby, K Cameron, R J Simes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group
M J Byrne, V Gebski, J Forbes, et al.
The British Journal of Surgery
|
September 10, 2015
Meta-analysis of radical resection rates and margin assessment in pancreatic cancer
M D Chandrasegaram, D Goldstein, J Simes, et al.
Journal of the American College of Cardiology
|
June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators
B K Metz, H D White, C B Granger, et al.
Lancet (London, England)
|
December 29, 2000
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study
A M Tonkin, D Colquhoun, J Emberson, et al.
JAMA
|
December 24, 1997
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review
W D Weaver, R J Simes, A Betriu, et al.
Circulation
|
September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators
R M Califf, H D White, F Van de Werf, et al.
Breast Cancer Research and Treatment
|
April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C
T J Price, D Zannino, K Wilson, et al.
Page
of 15